Treatment Goals for Low-Density Lipoprotein Cholesterol in the Secondary Prevention of Coronary Heart Disease: Absolute Levels or Extent of Lowering?

The results of the Scandinavian Simvastatin Survival Study (4S) and the Cholesterol and Recurrent Events (CARE) study make abundantly clear the benefits of lowering low-density lipoprotein (LDL) cholesterol in patients with a history of coronary artery di